Skip to main content
. 2009 Feb 5;27(25):3299–3305. doi: 10.1016/j.vaccine.2009.01.057

Fig. 2.

Fig. 2

Potency and stability of recombinant MVb-HIVs. (A) Growth kinetics of different rMVb-HIV-1 compared with the parental vaccine. Viruses were harvested daily from infected cell cultures, and virus shed was determined by plaque assays. (B) Stability of protein expression was determined by immunocytochemistry. Serially passaged viruses were inoculated onto cell monolayers and syncytia were stained with specific monoclonal antibodies and HRP.